Machine learning classification and regression algorithms were applied to calibrate the localization errors of a time-difference-of-arrival (TDOA)-based acoustic sensor array used for tracking salmon passage through a hydroelectric dam on the Snake River, Washington, USA. The locations of stationary and mobile acoustic tags were first tracked using the approximate maximum likelihood algorithm. Next, ensembles of classification trees successfully identified and filtered data points with large localization errors. This prefiltering step allowed the creation of a machine-learned regression model function, which decreased the median distance error by 50% for the stationary tracks and by 34% for the mobile tracks. It also extended the previous range of sub-meter localization accuracy from 100 m to 250 m horizontal distance from the dam face (the receivers). Median distance errors in the depth direction were especially decreased, falling from 0.49 m to 0.04 m in the stationary tracks and from 0.38 m to 0.07 m in the mobile tracks. These methods would have application to the calibration of error in any TDOA-based sensor network with a steady environment and array configuration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1063/1.5012687 | DOI Listing |
Drugs
January 2025
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Inavolisib (Itovebi) is an orally administered, phosphatidylinositol-3-kinase alpha (PI3Kα) inhibitor being developed by Genentech, a member of the Roche group, for the treatment of solid tumours. On 10 October 2024, inavolisib received its first approval in the USA in combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy. In the EU and other countries worldwide, regulatory review of inavolisib is currently underway.
View Article and Find Full Text PDFPurpose: We hypothesised that applying radiomics to [F]PSMA-1007 PET/CT images could help distinguish Unspecific Bone Uptakes (UBUs) from bone metastases in prostate cancer (PCa) patients. We compared the performance of radiomic features to human visual interpretation.
Materials And Methods: We retrospectively analysed 102 hormone-sensitive PCa patients who underwent [F]PSMA-1007 PET/CT and exhibited at least one focal bone uptake with known clinical follow-up (reference standard).
Radiology
January 2025
From the University of Maryland Medical Intelligent Imaging (UM2ii) Center, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD 21201 (C.H.S., A.K., V.P., F.X.D.); Departments of Radiology, Medicine, and Biomedical Data Science, Stanford University, Palo Alto, Calif (C.P.L.); Department of Computer Science and Electrical Engineering, College of Engineering and Information Technology, University of Maryland, Baltimore County, Baltimore, Md (A.J.); Department of Computer Science, University of Maryland, College Park, College Park, Md (H.H.); and University of Maryland Institute for Health Computing, University of Maryland, North Bethesda, Md (H.H., F.X.D.).
Integrating large language models (LLMs) into health care holds substantial potential to enhance clinical workflows and care delivery. However, LLMs also pose serious risks if integration is not thoughtfully executed, with complex challenges spanning accuracy, accessibility, privacy, and regulation. Proprietary commercial LLMs (eg, GPT-4 [OpenAI], Claude 3 Sonnet and Claude 3 Opus [Anthropic], Gemini [Google]) have received much attention from researchers in the medical domain, including radiology.
View Article and Find Full Text PDFAnn Med
December 2025
Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Background: Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. Traditional clinical characteristics alone are inadequate for accurately assessing the risk of NMIBC recurrence, necessitating the development of novel predictive tools.
Methods: We analyzed microarray data of NMIBC samples obtained from the ArrayExpress and GEO databases.
J Clin Endocrinol Metab
January 2025
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc UCL, Bruxelles, Belgium.
Introduction: Equivocal or negative pituitary magnetic resonance imaging (MRI) findings raise a significant challenge in the management of persistent or recurrent Cushing's disease (CD), compromising the chances of success of a further transsphenoidal surgery (TSS). The aim of our study was to determine the diagnostic utility of 11C-methionine (MET) positron emission tomography coupled with computerized tomography (PET/CT) in localizing the residual or relapsing corticotroph adenoma.
Methods: We retrospectively analyzed the results of 11C-MET PET/CT performed in two tertiary medical centers between May 2002 and November 2023 in 22 patients with a persisting or recurrent CD after initial TSS and equivocal or negative pituitary MRI findings.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!